Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin Lymphoma: Mayo Clinic experience
* Objective: To evaluate the overall risk of breast cancer and breast cancer characteristics in women given supradiaphragmatic radiation therapy for Hodgkin lymphoma. * Patients and Methods: Medical records of 653 female patients who received supradiaphragmatic radiation therapy for Hodgkin
Is lymphoma a type of cancer and how is it treated?
Lymphoma is a cancer of the lymph nodes and lymph system. Everyone has had a tender lymph node at one time or another during the course of an infection, and that's because their job is to make and store white blood cells that fight off infection. Cancer of the lymph nodes is called "lymphoma," and
Lymphoma enigma: AIDS-linked tumors may defy traditional views of cancer genesis.
Lymphoma Enigma AIDS-linked tumors may defy traditional views of cancer genesis For people with AIDS, survival means fighting one illness after another, as normally meek microbes slip past crippled immune defenses. And despite recent advances in treating these opportunistic infections, an
Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer lymphoma and melanoma
Oncological Applications of FDG PET Imaging: Brain Tumors, Colorectal Cancer Lymphoma and Melanoma* This article will focus primarily on body oncology diagnosis, staging and therapy monitoring using fluorodeoxyglucose (FDG) PET imaging. Common pitfalls and artifacts in body FDG imaging will be
Second cancers in survivors of Hodgkin Lymphoma: risks and recommendations.(Disease/Disorder overview)
Survivors of Hodgkin lymphoma (HL) who received certain oncology treatment years ago may have a lifelong risk for second cancers. This article reviews evidence-based data about subsequent solid tumor development in HL survivors. Regarding the development of solid cancer, a significant difference
Is the decline of the increasing incidence of non-Hodgkin lymphoma in Sweden and other countries a result of cancer preventive measures?
Is the decline of the increasing incidence of non-Hodgkin lymphoma (NHL) in Sweden and other countries a result of cancer preventive measures? The yearly age-standardized incidence of NHL increased significantly in Sweden during 1971-1990, for men an average of 3.2% and for women 3.1%. The
Is mouse mammary tumor virus an etiologic agent of human breast cancer and lymphoma?
In this issue of the Journal, Quilon et al present a patient with synchronous invasive breast cancer and low-grade lymphoma. There was no evidence of lymphoma outside the breast, and the two neoplasms demonstrated collision histology. The question is whether their case simply represents a chance
Fred Hutchinson Research Center Awarded $7 Million Grant To Lead Cancer Research Initiative; Investigation Is Part of The Leukemia & Lymphoma Society's $52 Million Global Research Program that Seeks to Find Cures for Blood Cancers.
WHITE PLAINS, N.Y. - The Leukemia & Lymphoma Society (the Society) announced it has awarded a $7 million grant through its Specialized Center of Research (SCOR) program to Dr. Irwin Bernstein, head of pediatric oncology research at the Fred Hutchinson Cancer Research Center in Seattle. Dr.
Primary Mammary (Non-Hodgkin) Lymphoma Presenting as Locally Advanced Breast Cancer
Primary mammary lymphoma is a rare tumor that presents commonly as a large mass with no specific mammographie appearance and can be confused with poorly differentiated carcinoma on frozen section. With appropriate treatment, this breast malignancy has a relatively good prognosis. We report a case
Mayo Clinic Cancer Center, Holden Comprehensive Cancer Center Win SPORE Grant for Lymphoma Cancer Research From NCI.
Byline: Mayo Clinic ROCHESTER, Minn., Sept. 18 (AScribe Newswire) - Mayo Clinic Cancer Center, in collaboration with the Holden Comprehensive Cancer Center at The University of Iowa in Iowa City, has received one of only two Specialized Programs of Research Excellence (SPORE) grants from the
